Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications

Fibrosing interstitial lung disease (ILD) is one of the most important causes of morbidity and mortality in patients with connective tissue diseases (CTDs), which include systemic sclerosis, rheumatoid arthritis, Sjögren’s syndrome, idiopathic inflammatory myositis and systemic lupus erythematosus....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drugs Context
Main Authors: Erre, Gian Luca, Sebastiani, Marco, Manfredi, Andreina, Gerratana, Elisabetta, Atzeni, Fabiola, Passiu, Giuseppe, Mangoni, Arduino A
Formato: Artigo
Idioma:Inglês
Publicado em: BioExcel Publishing Ltd 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7813437/
https://ncbi.nlm.nih.gov/pubmed/33505482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-8-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados